Skip to main navigation

Overview
News & Events
- News Releases
- Events
Stock Information
Financial & Filings
Governance
Responsibility
Investor Resources

News Releases

Year

28 Sep '23

Benchmarking Study Shows Streamlined Structural Variant Detection and High Concordance for OGM Compared to Chromosomal Microarray Analysis, the Global Standard in Genetic Disease Analysis

22 Sep '23

Bionano Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21 Sep '23

Bionano Announces Third OEM Partner has Received China NMPA Approval for DNA Isolation Products for IVD Use of OGM

14 Sep '23

Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease

06 Sep '23

Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia

30 Aug '23

Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development

28 Aug '23

Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health

21 Aug '23

Bionano Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement

16 Aug '23

Bionano Laboratories Receives College of American Pathologists (CAP) Accreditation for its Clinical Laboratory

14 Aug '23

Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Next page
Last page

Displaying 11 - 20 of 62

Print Page
Email Alerts
RSS Feeds

Request Email Alerts

© 2023 Bionano Genomics, Inc. All rights reserved. For Research Use Only. Not For Use In Diagnostic Procedures. | Legal Notice | Privacy Policy